All studies
Enrolling by invitationOBSERVATIONAL

Alzheimer's Disease Neuroimaging Initiative 4

ADNI4 is an important research study continuing years of work to better understand Alzheimer's disease. It's helping scientists discover how the disease develops and changes over time, affecting people with normal memory, mild memory problems, and dementia. This study collects information like memory test results, brain scans, and samples of blood or spinal fluid. The main goal is to find better ways to diagnose Alzheimer's and to help develop new treatments. It also explores how to best recruit people for studies and gather information, whether they visit a clinic or take part from home. Around 1,500 people aged 55 to 90 from the UK and Canada will be involved.

At a glance

Status
Enrolling by invitation
Sponsor
University of Southern California
Enrolment target
1,500
Start
09 Jun 2023
Estimated completion
31 Jul 2027

What is this study about?

The Alzheimer's Disease Neuroimaging Initiative 4, or ADNI4 for short, is a long-running research programme aimed at understanding Alzheimer's disease much better. Think of it as a significant detective effort carried out by scientists and doctors. For several years, previous ADNI studies have gathered vital information, and ADNI4 continues this important work. The study looks at people with normal memory, those with mild memory changes that don't affect daily life (called Mild Cognitive Impaired), and those with Alzheimer's dementia.

This study isn't about testing a new drug; instead, it's about looking closely at how Alzheimer's develops and changes in real people over time. Researchers collect different types of information, including detailed memory tests, special brain scans, blood tests, and sometimes samples of spinal fluid. By combining all this information, they hope to get a clearer picture of the disease. This will help them find 'biomarkers' – these are like early warning signs or clues in the body that can tell us if someone is at risk of Alzheimer's, how far it has progressed, or if a treatment is working.

Ultimately, the knowledge gained from ADNI4 is crucial for improving how we diagnose Alzheimer's disease and designing better clinical trials for new treatments in the future. The study also explores new ways for people to participate, either by visiting a clinic or sometimes by taking part from their own homes, which could make future research more accessible to everyone.

Key takeaways

  • ADNI4 is important research to understand Alzheimer's disease.
  • It helps develop biomarkers for diagnosis and treatment.
  • The study involves memory tests, brain scans, and blood samples.
  • It's an observational study, no new treatments are given.
  • Participants can take part for up to five years.
  • The study includes people with normal memory, mild memory issues, and dementia.

Who may be eligible?

ADNI4 is looking for around 1,500 people aged between 55 and 90 years old, from across the United States and Canada. They are interested in people from three different groups: those with normal memory, those with mild memory problems (Mild Cognitive Impairment), and those with Alzheimer's disease (dementia).

If you have normal memory, you would need to show good memory function on specific tests. You would also need to score well on a general mental abilities test (Mini-Mental State Exam) and not have any significant impacts on your daily life. It's important that any regular medications you take have been stable for at least 4 weeks, and certain other medications that affect the brain might need to be stopped beforehand.

If you have mild memory problems, you would need to be experiencing some memory concerns that you or someone close to you has noticed, and specific memory tests would confirm these changes. The study will look at your individual situation carefully to see if you're a good fit.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you between 55 and 90 years old?
  2. Do you have normal memory, mild memory problems, or a diagnosis of Alzheimer's dementia?
  3. Are you able to attend regular study visits or participate remotely?
  4. Are any regular medications you take currently stable?
  5. Are you comfortable with blood tests and potentially brain scans and a lumbar puncture?
Answer every question to see your result.

What does participation involve?

If you join ADNI4, you will be involved in the study for up to five years. During this time, you'll have regular visits where you'll undergo various assessments. This includes detailed memory and thinking tests, some of which might be done on a computer. You'll also have special brain scans, including PET scans (which look for specific proteins in the brain) and MRI scans (which give detailed pictures of the brain structure).

You'll also provide samples for biomarker and genetic testing, which could include blood tests and sometimes a lumbar puncture (spinal tap) to collect cerebrospinal fluid. All these tests help researchers understand how Alzheimer's progresses. The study is observational, meaning you won't be given any experimental treatments; instead, researchers are just watching and collecting information about how your condition changes over time. Some parts of the study might even be done from your home using web-based tools.

Potential risks and benefits

Taking part in any study has potential benefits and risks. A potential benefit of ADNI4 is contributing to vital research that could lead to better ways to diagnose and treat Alzheimer's disease in the future, helping countless others. You'll also receive careful monitoring of your memory and overall brain health throughout the study. Potential risks are generally related to the procedures involved, such as discomfort from blood draws, or a lumbar puncture, and exposure to a small amount of radiation from PET scans, similar to what you'd experience with other medical tests. There are no direct medical benefits from interventions, as this is an observational study. You always have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (62)

  • University of Alabama at Birmingham
    Verified postcode
    Birmingham, United States
  • Banner Alzheimer's Institute
    Verified postcode
    Phoenix, United States
  • Barrow Neurological Institute
    Verified postcode
    Phoenix, United States
  • Banner Sun Health Research Institute
    Verified postcode
    Sun City, United States
  • University of California, Irvine
    Verified postcode
    Irvine, United States
  • University of California, San Diego
    Verified postcode
    La Jolla, United States
  • University of California, Los Angeles
    Verified postcode
    Los Angeles, United States
  • University of Southern California
    Verified postcode
    Los Angeles, United States
  • Stanford University
    Verified postcode
    Palo Alto, United States
  • University of California, San Francisco
    Verified postcode
    San Francisco, United States
  • University of California, Davis
    Verified postcode
    Walnut Creek, United States
  • Yale University
    Verified postcode
    New Haven, United States

Common questions

What is the main goal of the ADNI4 study?

The main goal is to understand Alzheimer's disease better, improve how we diagnose it, and help design future studies for new treatments.

Will I be given any new medications or treatments in this study?

No, this is an observational study. You won't receive any experimental treatments; researchers are simply gathering information about the disease's progression.

How long will I need to be involved in the study?

You could be involved for up to five years, with regular check-ups and assessments during that time.

What kind of tests will I have if I join?

You'll have memory tests, brain scans (like MRI and PET scans), blood tests, and potentially a spinal fluid test (lumbar puncture).

Can I take part if I live in the UK?

Yes, the study is recruiting participants from both the United States and Canada.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Alzheimer's Disease Neuroimaging Initiative 4…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.